Healthy Heart Panel (Cardiac Biomarkers)

The Healthy Heart panel at IFCOR goes beyond the standard lipid check by adding two cardiac-specific biomarkers: Troponin I and NT-proBNP. Troponin I is a protein released from heart muscle when cardiac cells are damaged or stressed — elevated levels indicate myocardial injury and are the gold-standard marker for myocardial infarction diagnosis in hospitals. NT-proBNP is a hormone secreted by heart muscle cells under mechanical stretch or volume overload; elevated NT-proBNP is the most sensitive blood marker for heart failure, used internationally for diagnosis, prognosis, and treatment monitoring. Together with the lipid panel and glucose, this combination provides a cardiovascular health picture that goes significantly beyond what a standard annual blood test offers. It is designed for monitoring — not for acute chest pain, which requires emergency medical attention.

Cardiovascular disease remains the leading cause of premature death in the Czech Republic, and many cardiac conditions progress silently before producing symptoms. The Healthy Heart panel at IFCOR Jihlava introduces two cardiac-specific biomarkers that transform a standard cardiovascular screen into a meaningful cardiac health audit. Troponin I is a regulatory protein in cardiac muscle that is released into the bloodstream when cardiomyocytes (heart muscle cells) are damaged. In hospital settings, serial troponin measurements are used to diagnose NSTEMI (non-ST-elevation myocardial infarction) and other acute coronary syndromes. In a preventive context, mildly or chronically elevated high-sensitivity troponin has been shown in population studies to predict future cardiovascular events — meaning it can identify subclinical myocardial stress before a clinical event occurs. The laboratory emphasises that this test is not intended for self-diagnosis of acute chest pain: anyone with acute symptoms should attend an emergency department. NT-proBNP (N-terminal pro-B-type natriuretic peptide) is secreted primarily by ventricular cardiomyocytes in response to increased wall stress from volume or pressure overload. It is the most sensitive and specific blood marker available for cardiac insufficiency (heart failure) — guidelines from both the European Society of Cardiology and the Czech Cardiology Society recommend NT-proBNP as the primary screening and monitoring biomarker for heart failure in symptomatic patients and high-risk individuals. The complete panel also includes the standard lipid profile (total cholesterol, LDL, HDL, triglycerides) and fasting glucose — together with troponin and NT-proBNP, these markers provide a comprehensive picture of cardiac muscle health, atherogenic risk, and metabolic drivers of cardiovascular disease in a single fasting blood draw.